mepacrine (Collaborations Pharmaceuticals)

N/A

Report date: 2025/03/20 15:23:05
NME

Base Information

Drug Namemepacrine (Collaborations Pharmaceuticals)
Drug Alias Namequinacrine (Collaborations Pharmaceuticals)mepacrinequinacrine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCollaborations Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCollaborations Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A